Comparative in vitro activity of ceftobiprole against staphylococci displaying normal and small-colony variant phenotypes

Antimicrob Agents Chemother. 2005 Oct;49(10):4372-4. doi: 10.1128/AAC.49.10.4372-4374.2005.

Abstract

The antistaphylococcal activity of ceftobiprole was compared with those of cefuroxime, linezolid, and moxifloxacin by using the agar dilution method. Apart from three strains with small-colony variant phenotypes, all Staphylococcus aureus isolates tested were inhibited by < or =2 microg/ml of ceftobiprole. This compound exhibited an excellent antistaphylococcal activity, comparable to that of linezolid.

Publication types

  • Comparative Study

MeSH terms

  • Acetamides / pharmacology
  • Anti-Bacterial Agents / pharmacology*
  • Aza Compounds / pharmacology
  • Cefuroxime / pharmacology
  • Cephalosporins / pharmacology*
  • Fluoroquinolones
  • Genetic Variation*
  • Linezolid
  • Microbial Sensitivity Tests
  • Moxifloxacin
  • Oxazolidinones / pharmacology
  • Phenotype*
  • Quinolines / pharmacology
  • Staphylococcal Infections / drug therapy*
  • Staphylococcal Infections / microbiology
  • Staphylococcus / drug effects*
  • Staphylococcus / genetics
  • Staphylococcus / isolation & purification

Substances

  • Acetamides
  • Anti-Bacterial Agents
  • Aza Compounds
  • Cephalosporins
  • Fluoroquinolones
  • Oxazolidinones
  • Quinolines
  • ceftobiprole
  • Linezolid
  • Cefuroxime
  • Moxifloxacin